1 unknown. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
Follow Sivakami A Pai: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Intravitreal Bevacizumab for Threshold ROP. Intravitreal Bevacizumab - Stage 2+ or Stage 3+ Retinopathy of Prematurity in Zone I or Zone II. | Not applicable | Unknown | Sivakami A Pai | 50 | 2010-01-01 | 2012-10-16 |
United Arab Emirates (1)